A Georgetown associate professor of pharmacology recently warned of the health dangers potentially associated with low-T testosterone replacement therapy products like AndroGel, Axiron, and Testim. At the American Urological Association\u2019s annual meeting recently held in Orlando, Dr. Adriane Fugh-Berman said advertisers are attempting to turn aging \u201cinto a disease with very vague, non-specific symptoms that closely overlap with aging.\u201d<\/p>\n\n\n\n
\u201cThere is no evidence of benefits for testosterone and plenty of evidence of harm and cardiovascular risk,\u201d Dr. Fugh-Berman said. \u201cAdvertisers and some doctors say wonderful things about what testosterone does, but we\u2019ve had some studies that show there is cardiovascular risk associated<\/a> with it, and that is being ignored for whatever reason.\u201d<\/p>\n\n\n\n She compared the push to sell low-T testosterone products to men is similar to the marketing of estrogen treatments for women. Studies during the 1970s linked estrogen treatments with serious health problems, but the treatments soared in popularity until 2000 when a new study linked estrogen treatments with breast cancer and cardiovascular problems.<\/p>\n\n\n\n Two other doctors - Dr. Alvin Matsumoto of the University of Washington School of Medicine and Dr. Ajay Nangia of the University of Kansas Medical Center \u2013 also made presentations alleging that testosterone treatments such as Axiron, AndroGel, and Testim could be dangerous for men. Dr. Nangia stated that the guidelines for prescribing testosterone products are too broad and that there are too many signs and symptoms that can be attributed to low testosterone. Dr. Matsumoto criticized the practice of giving patients low-T prescriptions after only one testosterone test.<\/p>\n\n\n\n \u201cThere are clinics now that prescribe testosterone treatment after getting one reading, and I would argue that is not a good decision,\u201d Dr. Matsumoto said.<\/p>\n\n\n\n Last fall, Dr. Fugh-Berman wrote a column in the Chicago Tribune stating that testosterone drugs are \u201cassociated with more heart attacks, blood clots and anemia, worsening heart failure, and increased prostate cancer risk.\u201d She observed that studies funded by pharmaceutical companies seek to minimize these adverse health events.<\/p>\n\n\n\nOther doctors warn against testosterone treatments<\/h2>\n\n\n\n